Cong, Ze
Tran, Oth
Nelson, James
Silver, Monica
Chung, Karen
Funding for this research was provided by:
GRAIL LLC, a subsidiary of Illumina, Inc.
Article History
Accepted: 25 July 2022
First Online: 30 August 2022
Declarations
:
: This study was funded by Grail LLC, a subsidiary of Illumina, Inc.
: Ze Cong and Karen Chung are employed by GRAIL, LLC, a subsidiary of Illumina, Inc., Menlo Park, CA, USA* *GRAIL, LLC is currently held separate from Illumina Inc. under the terms of the Interim Measures Order of the European Commission dated 29 October 2021, and hold stock in Illumina, Inc. Oth Tran, James Nelson, and Monica Silver were or are employed by IBM Watson Health, which received funding from Grail LLC, a subsidiary of Illumina, Inc., to conduct this study.
: The data that support the findings of this study are available from IBM Watson Health. Restrictions apply to the availability of these data, which were used under license for this study.
: All authors contributed to the formulation and design of the study, preparation of the manuscript, and approved the final manuscript. OT, JN, and MS conducted the analyses.
: Not applicable.
: Not applicable.
: Not applicable.
: The codes generated during the current study are available from the corresponding author on reasonable request.